Pharmaceutical

Lilly and EVA Pharma to expand baricitinib access in Africa

Eli Lilly and EVA Pharma have formed a partnership to increase the availability of baricitinib in 49 African countries by 2030.

Sep 6, 2024 - 04:00
Lilly and EVA Pharma to expand baricitinib access in Africa
Eli Lilly and EVA Pharma have formed a partnership to increase the availability of baricitinib in 49 African countries by 2030.
Read the original article

Tags:

Previous Article

ArsenalBio secures $325m to develop cell therapy programmes

Next Article

Phase 2/3 of Athira Trial for Alzheimer’s Fails

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Genetically altered pig heart transplanted into a human for the second time

Genetically altered pig heart transplanted into a human...

Sep 22, 2023

Opinion: New federal guidance is hurting cancer patients, especially those in rural areas

Opinion: New federal guidance is hurting cancer patient...

Mar 2, 2024

Why do some women experience UTI pain with no clear infection? A mouse study offers clues

Why do some women experience UTI pain with no clear inf...

Mar 2, 2024